ID   FOSB_MOUSE              Reviewed;         338 AA.
AC   P13346;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   20-FEB-2007, entry version 54.
DE   Protein fosB.
GN   Name=Fosb;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=89251612; PubMed=2498083;
RA   Zerial M., Toschi L., Ryseck R.-P., Schuermann M., Mueller R.,
RA   Bravo R.;
RT   "The product of a novel growth factor activated gene, fos B, interacts
RT   with JUN proteins enhancing their DNA binding activity.";
RL   EMBO J. 8:805-813(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=92158623; PubMed=1741260; DOI=10.1093/nar/20.2.343;
RA   Lazo P.S., Dorfman K., Noguchi T., Mattei M.-G., Bravo R.;
RT   "Structure and mapping of the fosB gene. FosB downregulates the
RT   activity of the fosB promoter.";
RL   Nucleic Acids Res. 20:343-350(1992).
CC   -!- FUNCTION: FosB interacts with Jun proteins enhancing their DNA
CC       binding activity.
CC   -!- SUBUNIT: Heterodimer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- INDUCTION: By growth factors.
CC   -!- SIMILARITY: Belongs to the bZIP family. Fos subfamily.
CC   -!- SIMILARITY: Contains 1 bZIP domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14897; CAA33026.1; -; mRNA.
DR   EMBL; AF093624; AAD13196.1; -; Genomic_DNA.
DR   PIR; S35477; TVMSFB.
DR   UniGene; Mm.248335; -.
DR   HSSP; P01100; 1FOS.
DR   SMR; P13346; 157-215.
DR   DIP; DIP:1067N; -.
DR   TRANSFAC; T00291; -.
DR   Ensembl; ENSMUSG00000003545; Mus musculus.
DR   KEGG; mmu:14282; -.
DR   MGI; MGI:95575; Fosb.
DR   ArrayExpress; P13346; -.
DR   GermOnline; ENSMUSG00000003545; Mus musculus.
DR   InterPro; IPR011700; bZIP_2.
DR   InterPro; IPR008917; Euk_TF_DNA_bd.
DR   InterPro; IPR000837; Leuzip_Fos.
DR   InterPro; IPR004827; TF_bZIP.
DR   Pfam; PF07716; bZIP_2; 1.
DR   PRINTS; PR00042; LEUZIPPRFOS.
DR   SMART; SM00338; BRLZ; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
KW   DNA-binding; Nuclear protein.
FT   CHAIN         1    338       Protein fosB.
FT                                /FTId=PRO_0000076477.
FT   DOMAIN      183    211       Leucine-zipper.
FT   DNA_BIND    161    179       Basic motif.
SQ   SEQUENCE   338 AA;  35977 MW;  E9D031A4BEAE48EC CRC64;
     MFQAFPGDYD SGSRCSSSPS AESQYLSSVD SFGSPPTAAA SQECAGLGEM PGSFVPTVTA
     ITTSQDLQWL VQPTLISSMA QSQGQPLASQ PPAVDPYDMP GTSYSTPGLS AYSTGGASGS
     GGPSTSTTTS GPVSARPARA RPRRPREETL TPEEEEKRRV RRERNKLAAA KCRNRRRELT
     DRLQAETDQL EEEKAELESE IAELQKEKER LEFVLVAHKP GCKIPYEEGP GPGPLAEVRD
     LPGSTSAKED GFGWLLPPPP PPPLPFQSSR DAPPNLTASL FTHSEVQVLG DPFPVVSPSY
     TSSFVLTCPE VSAFAGAQRT SGSEQPSDPL NSPSLLAL
//

ID   CAC1C_RAT               Reviewed;        2169 AA.
AC   P22002; P27733; P27734; Q62816; Q63271; Q64178;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   05-OCT-2010, entry version 106.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1C;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;
DE   AltName: Full=Rat brain class C;
DE            Short=RBC;
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.2;
GN   Name=Cacna1c; Synonyms=Cach2, Cacn2, Cacnl1a1, Cchl1a1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Aorta;
RX   MEDLINE=91009241; PubMed=2170396;
RA   Koch W.J., Ellinor P.T., Schwartz A.;
RT   "cDNA cloning of a dihydropyridine-sensitive calcium channel from rat
RT   aorta. Evidence for the existence of alternatively spliced forms.";
RL   J. Biol. Chem. 265:17786-17791(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5).
RC   TISSUE=Brain;
RX   MEDLINE=91299339; PubMed=1648941; DOI=10.1016/0896-6273(91)90073-9;
RA   Snutch T.P., Tomlinson W.J., Leonard J.P., Gilbert M.M.;
RT   "Distinct calcium channels are generated by alternative splicing and
RT   are differentially expressed in the mammalian CNS.";
RL   Neuron 7:45-57(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1168-1413 (ISOFORM 1).
RX   MEDLINE=90239020; PubMed=1692134; DOI=10.1073/pnas.87.9.3391;
RA   Snutch T.P., Leonard J.P., Gilbert M.M., Lester H.A., Davidson N.;
RT   "Rat brain expresses a heterogeneous family of calcium channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:3391-3395(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 1269-1415 (ISOFORMS 1; 2 AND 3).
RX   MEDLINE=92159076; PubMed=1311102; DOI=10.1073/pnas.89.4.1497;
RA   Diebold R.J., Koch W.J., Ellinor P.T., Wang J.-J., Muthuchamy M.,
RA   Wieczorek D.F., Schwartz A.;
RT   "Mutually exclusive exon splicing of the cardiac calcium channel a1
RT   subunit generates developmentally regulated isoforms in the rat
RT   heart.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1497-1501(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1269-1387.
RC   TISSUE=Myometrium;
RX   MEDLINE=96043375; PubMed=7485440;
RA   Tezuka N., Ali M., Chwalisz K., Garfield R.E.;
RT   "Changes in transcripts encoding calcium channel subunits of rat
RT   myometrium during pregnancy.";
RL   Am. J. Physiol. 269:C1008-C1017(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1202-1495 (ISOFORM 3).
RC   TISSUE=Osteosarcoma;
RX   MEDLINE=96074617; PubMed=7479909; DOI=10.1073/pnas.92.24.10914;
RA   Barry E.L.R., Gesek F.A., Froehner S.C., Friedman P.A.;
RT   "Multiple calcium channel transcripts in rat osteosarcoma cells:
RT   selective activation of alpha 1D isoform by parathyroid hormone.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10914-10918(1995).
RN   [7]
RP   PHOSPHORYLATION.
RX   MEDLINE=93374932; PubMed=8396138;
RA   Hell J.W., Yokoyama C.T., Wong S.T., Warner C., Snutch T.P.,
RA   Catterall W.A.;
RT   "Differential phosphorylation of two size forms of the neuronal class
RT   C L-type calcium channel alpha 1 subunit.";
RL   J. Biol. Chem. 268:19451-19457(1993).
RN   [8]
RP   INTERACTION WITH CABP1.
RX   PubMed=15140941; DOI=10.1523/JNEUROSCI.5523-03.2004;
RA   Zhou H., Kim S.-A., Kirk E.A., Tippens A.L., Sun H., Haeseleer F.,
RA   Lee A.;
RT   "Ca2+-binding protein-1 facilitates and forms a postsynaptic complex
RT   with Cav1.2 (L-type) Ca2+ channels.";
RL   J. Neurosci. 24:4698-4708(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 452-476.
RX   PubMed=15170217; DOI=10.1038/nature02641;
RA   Chen Y.H., Li M.H., Zhang Y., He L.L., Yamada Y., Fitzmaurice A.,
RA   Shen Y., Zhang H., Tong L., Yang J.;
RT   "Structural basis of the alpha1-beta subunit interaction of voltage-
RT   gated Ca2+ channels.";
RL   Nature 429:675-680(2004).
CC   -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the
CC       entry of calcium ions into excitable cells and are also involved
CC       in a variety of calcium-dependent processes, including muscle
CC       contraction, hormone or neurotransmitter release, gene expression,
CC       cell motility, cell division and cell death. The isoform alpha-1C
CC       gives rise to L-type calcium currents. Long-lasting (L-type)
CC       calcium channels belong to the 'high-voltage activated' (HVA)
CC       group. They are blocked by dihydropyridines (DHP),
CC       phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA
CC       (omega-Aga-IIIA). They are however insensitive to omega-conotoxin-
CC       GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA).
CC       Calcium channels containing the alpha-1C subunit play an important
CC       role in excitation-contraction coupling in the heart. Binding of
CC       calmodulin or CABP1 at the same regulatory sites results in an
CC       opposit effects on the channel function.
CC   -!- SUBUNIT: Voltage-dependent calcium channels are multisubunit
CC       complexes, consisting of alpha-1, alpha-2, beta and delta subunits
CC       in a 1:1:1:1 ratio. The channel activity is directed by the pore-
CC       forming and voltage-sensitive alpha-1 subunit. In many cases, this
CC       subunit is sufficient to generate voltage-sensitive calcium
CC       channel activity. The auxiliary subunits beta and alpha-2/delta
CC       linked by a disulfide bridge regulate the channel activity.
CC       Interacts (via C-terminal C and IQ motifs) with CABP1. The binding
CC       via the C motif is calcium independent whereas the binding via IQ
CC       requires the presence of calcium and is mutually exclusive with
CC       calmodulin binding. Interacts with CACNA2D4 (By similarity).
CC       Interacts (via C-terminal CDB motif) with CABP5; in a calcium-
CC       dependent manner (By similarity).
CC   -!- INTERACTION:
CC       O88751:Cabp1; NbExp=1; IntAct=EBI-1185084, EBI-1185073;
CC       Q8CFG6:Cacna2d2; NbExp=1; IntAct=EBI-1185084, EBI-2465752;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell
CC       membrane (By similarity). Note=The interaction between RRAD and
CC       CACNB2 regulates its trafficking to the cell membrane (By
CC       similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist;
CC       Name=2; Synonyms=S3B;
CC         IsoId=P22002-1; Sequence=Displayed;
CC       Name=1; Synonyms=S3A;
CC         IsoId=P22002-2; Sequence=VSP_000911;
CC       Name=3; Synonyms=D1, ROB2;
CC         IsoId=P22002-3; Sequence=VSP_000912;
CC       Name=4; Synonyms=rbC-I;
CC         IsoId=P22002-4; Sequence=VSP_000908, VSP_000910, VSP_000911;
CC       Name=5; Synonyms=rbC-II;
CC         IsoId=P22002-5; Sequence=VSP_000908, VSP_000909, VSP_000910;
CC   -!- TISSUE SPECIFICITY: Isoforms 4 and 5 are expressed throughout the
CC       central nervous system, with highest levels in the olfactory bulb
CC       and cerebellum. Also expressed in heart, pituitary, adrenal gland,
CC       liver, kidney, and in a much lesser extent in testes and spleen.
CC   -!- DEVELOPMENTAL STAGE: Expressed from embryonic day 16 until the
CC       adult stage.
CC   -!- DOMAIN: Each of the four internal repeats contains five
CC       hydrophobic transmembrane segments (S1, S2, S3, S5, S6) and one
CC       positively charged transmembrane segment (S4). S4 segments
CC       probably represent the voltage-sensor and are characterized by a
CC       series of positively charged amino acids at every third position.
CC   -!- DOMAIN: Binding of intracellular calcium through the EF-hand motif
CC       inhibits the opening of the channel (By similarity).
CC   -!- PTM: Phosphorylation by PKA activates the channel (Probable). Is
CC       also phosphorylated in vitro by CaM-kinase II, PKC and CGPK.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit
CC       (TC 1.A.1.11) family. CACNA1C subfamily.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M59786; AAA85463.1; -; mRNA.
DR   EMBL; M67515; AAA18905.1; -; mRNA.
DR   EMBL; M67516; AAA42016.1; -; mRNA.
DR   EMBL; M91242; AAA41460.1; -; Genomic_DNA.
DR   EMBL; M91240; AAA41460.1; JOINED; Genomic_DNA.
DR   EMBL; M89924; AAA41460.1; JOINED; Genomic_DNA.
DR   EMBL; M91241; AAA41460.1; JOINED; Genomic_DNA.
DR   EMBL; S80558; AAB35528.1; -; mRNA.
DR   EMBL; U31815; AAA89157.1; -; mRNA.
DR   IPI; IPI00231323; -.
DR   IPI; IPI00392650; -.
DR   IPI; IPI00476992; -.
DR   IPI; IPI00948183; -.
DR   IPI; IPI00949968; -.
DR   RefSeq; NP_036649.2; -.
DR   UniGene; Rn.9827; -.
DR   PDB; 1VYT; X-ray; 2.60 A; E/F=452-476.
DR   PDBsum; 1VYT; -.
DR   ProteinModelPortal; P22002; -.
DR   SMR; P22002; 151-234, 1641-1669.
DR   IntAct; P22002; 3.
DR   STRING; P22002; -.
DR   PhosphoSite; P22002; -.
DR   Ensembl; ENSRNOT00000052017; ENSRNOP00000048790; ENSRNOG00000007090.
DR   GeneID; 24239; -.
DR   KEGG; rno:24239; -.
DR   UCSC; M67516; rat.
DR   UCSC; NM_012517; rat.
DR   CTD; 24239; -.
DR   RGD; 2245; Cacna1c.
DR   eggNOG; maNOG17008; -.
DR   HOVERGEN; HBG050763; -.
DR   InParanoid; P22002; -.
DR   PhylomeDB; P22002; -.
DR   ArrayExpress; P22002; -.
DR   Genevestigator; P22002; -.
DR   GermOnline; ENSRNOG00000007090; Rattus norvegicus.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0005624; C:membrane fraction; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0030315; C:T-tubule; IDA:RGD.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IPI:RGD.
DR   InterPro; IPR005821; Ion_trans.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR005451; VDCC_L_a1csu.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   PANTHER; PTHR10037:SF47; LVDCCAlpha1C; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01635; LVDCCALPHA1C.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion transport; Ionic channel; Membrane; Phosphoprotein; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1   2169       Voltage-dependent L-type calcium channel
FT                                subunit alpha-1C.
FT                                /FTId=PRO_0000053931.
FT   TOPO_DOM      1    154       Cytoplasmic (Potential).
FT   TRANSMEM    155    173       Helical; Name=S1 of repeat I;
FT                                (Potential).
FT   TOPO_DOM    174    190       Extracellular (Potential).
FT   TRANSMEM    191    211       Helical; Name=S2 of repeat I;
FT                                (Potential).
FT   TOPO_DOM    212    223       Cytoplasmic (Potential).
FT   TRANSMEM    224    242       Helical; Name=S3 of repeat I;
FT                                (Potential).
FT   TOPO_DOM    243    262       Extracellular (Potential).
FT   TRANSMEM    263    281       Helical; Name=S4 of repeat I;
FT                                (Potential).
FT   TOPO_DOM    282    300       Cytoplasmic (Potential).
FT   TRANSMEM    301    320       Helical; Name=S5 of repeat I;
FT                                (Potential).
FT   TOPO_DOM    321    410       Extracellular (Potential).
FT   TRANSMEM    411    435       Helical; Name=S6 of repeat I;
FT                                (Potential).
FT   TOPO_DOM    436    554       Cytoplasmic (Potential).
FT   TRANSMEM    555    573       Helical; Name=S1 of repeat II;
FT                                (Potential).
FT   TOPO_DOM    574    588       Extracellular (Potential).
FT   TRANSMEM    589    608       Helical; Name=S2 of repeat II;
FT                                (Potential).
FT   TOPO_DOM    609    616       Cytoplasmic (Potential).
FT   TRANSMEM    617    635       Helical; Name=S3 of repeat II;
FT                                (Potential).
FT   TOPO_DOM    636    645       Extracellular (Potential).
FT   TRANSMEM    646    664       Helical; Name=S4 of repeat II;
FT                                (Potential).
FT   TOPO_DOM    665    683       Cytoplasmic (Potential).
FT   TRANSMEM    684    703       Helical; Name=S5 of repeat II;
FT                                (Potential).
FT   TOPO_DOM    704    758       Extracellular (Potential).
FT   TRANSMEM    759    783       Helical; Name=S6 of repeat II;
FT                                (Potential).
FT   TOPO_DOM    784    930       Cytoplasmic (Potential).
FT   TRANSMEM    931    949       Helical; Name=S1 of repeat III;
FT                                (Potential).
FT   TOPO_DOM    950    965       Extracellular (Potential).
FT   TRANSMEM    966    985       Helical; Name=S2 of repeat III;
FT                                (Potential).
FT   TOPO_DOM    986    997       Cytoplasmic (Potential).
FT   TRANSMEM    998   1016       Helical; Name=S3 of repeat III;
FT                                (Potential).
FT   TOPO_DOM   1017   1023       Extracellular (Potential).
FT   TRANSMEM   1024   1041       Helical; Name=S4 of repeat III;
FT                                (Potential).
FT   TOPO_DOM   1042   1060       Cytoplasmic (Potential).
FT   TRANSMEM   1061   1080       Helical; Name=S5 of repeat III;
FT                                (Potential).
FT   TOPO_DOM   1081   1170       Extracellular (Potential).
FT   TRANSMEM   1171   1195       Helical; Name=S6 of repeat III;
FT                                (Potential).
FT   TOPO_DOM   1196   1248       Cytoplasmic (Potential).
FT   TRANSMEM   1249   1267       Helical; Name=S1 of repeat IV;
FT                                (Potential).
FT   TOPO_DOM   1268   1282       Extracellular (Potential).
FT   TRANSMEM   1283   1302       Helical; Name=S2 of repeat IV;
FT                                (Potential).
FT   TOPO_DOM   1303   1310       Cytoplasmic (Potential).
FT   TRANSMEM   1311   1329       Helical; Name=S3 of repeat IV;
FT                                (Potential).
FT   TOPO_DOM   1330   1353       Extracellular (Potential).
FT   TRANSMEM   1354   1372       Helical; Name=S4 of repeat IV;
FT                                (Potential).
FT   TOPO_DOM   1373   1391       Cytoplasmic (Potential).
FT   TRANSMEM   1392   1411       Helical; Name=S5 of repeat IV;
FT                                (Potential).
FT   TOPO_DOM   1412   1480       Extracellular (Potential).
FT   TRANSMEM   1481   1505       Helical; Name=S6 of repeat IV;
FT                                (Potential).
FT   TOPO_DOM   1506   2169       Cytoplasmic (Potential).
FT   REPEAT      141    438       I.
FT   REPEAT      540    786       II.
FT   REPEAT      917   1198       III.
FT   REPEAT     1235   1508       IV.
FT   CA_BIND    1534   1545       By similarity.
FT   REGION      458    475       Binding to the beta subunit (By
FT                                similarity).
FT   REGION     1118   1208       Dihydropyridine binding (By similarity).
FT   REGION     1459   1527       Dihydropyridine binding (By similarity).
FT   REGION     1473   1516       Phenylalkylamine binding (By similarity).
FT   COMPBIAS    684    690       Poly-Leu.
FT   COMPBIAS    798    804       Poly-Glu.
FT   COMPBIAS   1176   1182       Poly-Ile.
FT   SITE        393    393       Calcium ion selectivity and permeability
FT                                (By similarity).
FT   SITE        736    736       Calcium ion selectivity and permeability
FT                                (By similarity).
FT   SITE       1116   1116       Calcium ion selectivity and permeability
FT                                (By similarity).
FT   SITE       1445   1445       Calcium ion selectivity and permeability
FT                                (By similarity).
FT   MOD_RES     845    845       Phosphoserine (By similarity).
FT   MOD_RES    1516   1516       Phosphoserine; by PKA (Potential).
FT   MOD_RES    1919   1919       Phosphoserine; by PKA (Potential).
FT   MOD_RES    1927   1927       Phosphoserine; by PKA (Potential).
FT   CARBOHYD    183    183       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    358    358       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1417   1417       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD   1468   1468       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ       1     46       MIRAFAQPSTPPYQPLSSCLSEDTERKFKGKVVHEAQLNCF
FT                                YISPG -> MVNENTRMYVPEENHQ (in isoform 4
FT                                and isoform 5).
FT                                /FTId=VSP_000908.
FT   VAR_SEQ     810    810       R -> RPAR (in isoform 5).
FT                                /FTId=VSP_000909.
FT   VAR_SEQ     964    979       FYFDIVFTTIFTIEIA -> GNADYVFTSIFTLEII (in
FT                                isoform 4 and isoform 5).
FT                                /FTId=VSP_000910.
FT   VAR_SEQ    1306   1333       HYFCDAWNTFDALIVVGSIVDIAITEVH -> GYFSDPSNV
FT                                FDFLIVIGSIIAVILSETN (in isoform 1 and
FT                                isoform 4).
FT                                /FTId=VSP_000911.
FT   VAR_SEQ    1334   1344       Missing (in isoform 3).
FT                                /FTId=VSP_000912.
FT   CONFLICT     83     83       L -> Q (in Ref. 2; AAA18905/AAA42016).
FT   CONFLICT     87     87       D -> G (in Ref. 2; AAA18905).
FT   CONFLICT    520    520       G -> R (in Ref. 2; AAA18905).
FT   CONFLICT    648    649       CW -> VL (in Ref. 2; AAA18905/AAA42016).
FT   CONFLICT    678    678       L -> V (in Ref. 2; AAA18905/AAA42016).
FT   CONFLICT    769    770       SP -> CG (in Ref. 2; AAA18905/AAA42016).
FT   CONFLICT    777    777       L -> V (in Ref. 2; AAA18905/AAA42016).
FT   CONFLICT    871    871       D -> N (in Ref. 2; AAA18905).
FT   CONFLICT   1037   1037       R -> RA (in Ref. 2; AAA18905/AAA42016).
FT   CONFLICT   1098   1098       S -> C (in Ref. 2; AAA18905/AAA42016).
FT   CONFLICT   1107   1107       T -> D (in Ref. 2; AAA18905/AAA42016).
FT   CONFLICT   1229   1229       P -> R (in Ref. 2, 3 and 6).
FT   CONFLICT   1306   1306       H -> D (in Ref. 5).
FT   CONFLICT   1306   1306       H -> G (in Ref. 2; AAA42016).
FT   CONFLICT   1329   1329       I -> L (in Ref. 5).
FT   CONFLICT   1471   1471       E -> K (in Ref. 2; AAA18905).
FT   CONFLICT   1911   1911       C -> S (in Ref. 2; AAA18905/AAA42016).
FT   CONFLICT   2084   2084       K -> N (in Ref. 2; AAA18905).
FT   CONFLICT   2154   2154       R -> Q (in Ref. 2; AAA42016).
FT   HELIX       454    474
SQ   SEQUENCE   2169 AA;  243482 MW;  D3ADBD20E4763B69 CRC64;
     MIRAFAQPST PPYQPLSSCL SEDTERKFKG KVVHEAQLNC FYISPGGSNY GSPRPAHANM
     NANAAAGLAP EHIPTPGAAL SWLAAIDAAR QAKLMGSAGN ATISTVSSTQ RKRQQYGKPK
     KQGGTTATRP PRALLCLTLK NPIRRACISI VEWKPFEIII LLTIFANCVA LAIYIPFPED
     DSNATNSNLE RVEYLFLIIF TVEAFLKVIA YGLLFHPNAY LRNGWNLLDF IIVVVGLFSA
     ILEQATKADG ANALGGKGAG FDVKALRAFR VLRPLRLVSG VPSLQVVLNS IIKAMVPLLH
     IALLVLFVII IYAIIGLELF MGKMHKTCYN QEGIIDVPAE EDPSPCALET GHGRQCQNGT
     VCKPGWDGPK HGITNFDNFA FAMLTVFQCI TMEGWTDVLY WMQDAMGYEL PWVYFVSLVI
     FGSFFVLNLV LGVLSGEFSK EREKAKARGD FQKLREKQQL EEDLKGYLDW ITQAEDIDPE
     NEDEGMDEDK PRNMSMPTSE TESVNTENVA GGDIEGENCG ARLAHRISKS KFSRYWRRWN
     RFCRRKCRAA VKSNVFYWLV IFLVFLNTLT IASEHYNQPH WLTEVQDTAN KALLALFTAE
     MLLKMYSLGL QAYFVSLFNR FDCFIVCGGI LETILVETKI MSPLGISCWR CVRLLRIFKI
     TRYWNSLSNL VASLLNSLRS IASLLLLLFL FIIIFSLLGM QLFGGKFNFD EMQTRRSTFD
     NFPQSLLTVF QILTGEDWNS VMYDGIMAYG GPSFPGMLVC IYFIILFISP NYILLNLFLA
     IAVDNLADAE SLTSAQKEEE EEKERKKLAR TASPEKKQEV MEKPAVEESK EEKIELKSIT
     ADGESPPTTK INMDDLQPSE NEDKSPHSNP DTAGEEDEEE PEMPVGPRPR PLSELHLKEK
     AVPMPEASAF FIFSPNNRFR LQCHRIVNDT IFTNLILFFI LLSSISLAAE DPVQHTSFRN
     HILFYFDIVF TTIFTIEIAL KMTAYGAFLH KGSFCRNYFN ILDLLVVSVS LISFGIQSSA
     INVVKILRVL RVLRPLRINR AKGLKHVVQC VFVAIRTIGN IVIVTTLLQF MFACIGVQLF
     KGKLYTCSDS SKQTEAESKG NYITYKTGEV DHPIIQPRSW ENSKFDFDNV LAAMMALFTV
     STFEGWPELL YRSIDSHTED KGPIYNYRVE ISIFFIIYII IIAFFMMNIF VGFVIVTFQE
     QGEQEYKNCE LDKNQRQCVE YALKARPLPR YIPKNQHQYK VWYVVNSTYF EYLMFVLILL
     NTICLAMQHY GQSCLFKIAM NILNMLFTGL FTVEMILKLI AFKPKHYFCD AWNTFDALIV
     VGSIVDIAIT EVHPAEHTQC SPSMSAEENS RISITFFRLF RVMRLVKLLS RGEGIRTLLW
     TFIKSFQALP YVALLIVMLF FIYAVIGMQV FGKIALNDTT EINRNNNFQT FPQAVLLLFR
     CATGEAWQDI MLACMPGKKC APESEPSNST EGETPCGSSF AVFYFISFYM LCAFLIINLF
     VAVIMDNFDY LTRDWSILGP HHLDEFKRIW AEYDPEAKGR IKHLDVVTLL RRIQPPLGFG
     KLCPHRVACK RLVSMNMPLN SDGTVMFNAT LFALVRTALR IKTEGNLEQA NEELRAIIKK
     IWKRTSMKLL DQVVPPAGDD EVTVGKFYAT FLIQEYFRKF KKRKEQGLVG KPSQRNALSL
     QAGLRTLHDI GPEIRRAISG DLTAEEELDK AMKEAVSAAS EDDIFRRAGG LFGNHVSYYQ
     SDSRSNFPQT FATQRPLHIN KTGNNQADTE SPSHEKLVDS TFTPSSYSST GSNANINNAN
     NTALGRFPHP AGYSSTVSTV EGHGPPLSPA VRVQEAAWKL SSKRCHSRES QGATVSQDMF
     PDETRSSVRL SEEVEYCSEP SLLSTDILSY QDDENRQLTC LEEDKREIQP CPKRSFLRSA
     SLGRRASFHL ECLKRQKDQG GDISQKTALP LHLVHHQALA VAGLSPLLQR SHSPSTFPRP
     RPTPPVTPGS RGRPLQPIPT LRLEGAESSE KLNSSFPSIH CSSWSEETTA CSGGSSMARR
     ARPVSLTVPS QAGAPGRQFH GSASSLVEAV LISEGLGQFA QDPKFIEVTT QELADACDMT
     IEEMENAADN ILSGGAQQSP NGTLLPFVNC RDPGQDRAVV PEDESCVYAL GRGRSEEALP
     DSRSYVSNL
//

